Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A
The main complication of hemophilia A treatment is the development of neutralizing antibodies (inhibitors) against factor VIII (FVIII). Immune tolerance induction (ITI) is the prescribed treatment for inhibitor eradication, although its working mechanism remains unresolved. To clarify this mechanism...
Main Authors: | Sarah J. Schep, Roger E. G. Schutgens, Kathelijn Fischer, Jan Voorberg, Marianne Boes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000557 |
Similar Items
-
Gene Therapy in Hemophilia: From Hype to Hope
by: Roger Schutgens
Published: (2018-04-01) -
Immune tolerance induction in a severe hemophilia B child with low titer inhibitors
by: Asia Almulla, et al.
Published: (2022-01-01) -
Gene Therapy for Hemophilia A: How Long Will It Last?
by: Roger E. G. Schutgens
Published: (2022-06-01) -
Experience of induction of immune tolerance in patients with inhibitor form of hemophilia A in the presence of negative prognostic factors
by: N. I. Zozulya
Published: (2008-12-01) -
Clinical Care of Bone Health in Patients on the Immune Tolerance Induction’s Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia
by: Zahra Rezaieyazdi MD, et al.
Published: (2020-06-01)